Please use this identifier to cite or link to this item:
https://hdl.handle.net/10419/42042
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Boscheck, Ralf | en |
dc.date.accessioned | 2010-12-01T09:41:31Z | - |
dc.date.available | 2010-12-01T09:41:31Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | |aIntereconomics|c0020-5346|v43|h5|nSpringer|lHeidelberg|y2008|p277-281 | en |
dc.identifier.pi | doi:10.1007/s10272-008-0261-z | en |
dc.identifier.uri | http://hdl.handle.net/10419/42042 | - |
dc.language.iso | eng | en |
dc.publisher | |aSpringer |cHeidelberg | en |
dc.subject.ddc | 330 | en |
dc.subject.stw | Arzneimittelrecht | en |
dc.subject.stw | Verbraucherschutz | en |
dc.subject.stw | Pharmazeutisches Produkt | en |
dc.subject.stw | Deregulierung | en |
dc.subject.stw | Gesundheitswesen | en |
dc.subject.stw | USA | en |
dc.subject.stw | Deutschland | en |
dc.title | Off-label drugs vs. the merits of centralised regulatory control | - |
dc.type | |aArticle | en |
dc.rights | http://www.econstor.eu/dspace/Nutzungsbedingungen | en |
dc.identifier.printppn | 582112257 | en |
econstor.documentversion | Published Version | en |
econstor.citation.journaltitle | Intereconomics | en |
econstor.citation.issn | 0020-5346 | en |
econstor.citation.volume | 43 | en |
econstor.citation.issue | 5 | en |
econstor.citation.publisher | Springer | en |
econstor.citation.publisherplace | Heidelberg | en |
econstor.citation.year | 2008 | en |
econstor.citation.startpage | 277 | en |
econstor.citation.endpage | 281 | en |
Files in This Item:
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.